Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis
Science Immunology · 2024
DOI: 10.1126/sciimmunol.adi0042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2024. Verfasst von Xun Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immune Regulation and Cancer, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 81 Literaturangaben.
Abstract (Originalsprache)
Familial hemophagocytic lymphohistiocytosis (FHL) is an inherited, often fatal immune deficiency characterized by severe systemic hyperinflammation. Although allogeneic bone marrow transplantation can be curative, more effective therapies are urgently needed. FHL is caused by inactivating mutations in proteins that regulate cellular immunity. Here, we used an adeno-associated virus–based CRISPR-Cas9 system with an inhibitor of nonhomologous end joining to repair such mutations in potentially long-lived T cells ex vivo. Repaired CD8 memory T cells efficiently cured lethal hyperinflammation in a mouse model of Epstein-Barr virus–triggered FHL2, a subtype caused by perforin-1 ( Prf1 ) deficiency. Furthermore, repair of PRF1 and Munc13-4 ( UNC13D )—whose deficiency causes the FHL subtype FHL3—in mutant memory T cells from two critically ill patients with FHL restored T cell cytotoxicity. These results provide a starting point for the treatment of genetic T cell immune dysregulation syndromes with repaired autologous T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Immune Regulation and Cancer, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
- Immune Mechanisms and Human Antibodies, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
- Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), 10117 Berlin, Germany.
- Developmental Biology/Signal Transduction, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
- Center of Biological Design, Berlin Institute of Health (BIH) at Charité, 13125 Berlin, Germany.
- Genome Engineering & Disease Models, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
ORCID-Profile: Xun Li, Tristan Wirtz, Timm Weber, Mikhail Lebedin, Elijah D Lowenstein, Thomas Sommermann, Tomoharu Yasuda, Kathrin de la Rosa, Van Trung Chu, Johannes H Schulte, Ingo Müller, Christine Kocks, Klaus Rajewsky
Zitieren
APA
Li, X., Wirtz, T., Weber, T., Lebedin, M., Lowenstein, E. D., Sommermann, T., Zach, A., Yasuda, T., de la Rosa, K., Chu, V. T., Schulte, J. H., Müller, I., Kocks, C., & Rajewsky, K. (2024). Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis. Science Immunology. https://doi.org/10.1126/sciimmunol.adi0042
Vancouver
Li X, Wirtz T, Weber T, Lebedin M, Lowenstein ED, Sommermann T, et al. Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis. Science Immunology. 2024. doi:10.1126/sciimmunol.adi0042
BibTeX
@article{Li2024,
author = {Li, Xun and Wirtz, Tristan and Weber, Timm and Lebedin, Mikhail and Lowenstein, Elijah D and Sommermann, Thomas and Zach, Andreas and Yasuda, Tomoharu and de la Rosa, Kathrin and Chu, Van Trung and Schulte, Johannes H and Müller, Ingo and Kocks, Christine and Rajewsky, Klaus},
title = {Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis},
journal = {Science Immunology},
year = {2024},
doi = {10.1126/sciimmunol.adi0042}
}
EUVIMED